Sintx Technologies (NASDAQ:SINT) Shares Down 1.4% – Should You Sell?

Sintx Technologies, Inc. (NASDAQ:SINT) shares were down 1.4% during mid-day trading on Tuesday . The company traded as low as $2.71 and last traded at $2.78. Approximately 33,770 shares were traded during mid-day trading, an increase of 6% from the average daily volume of 31,767 shares. The stock had previously closed at $2.82.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on SINT shares. Ascendiant Capital Markets lowered their price target on Sintx Technologies from $25.00 to $16.00 and set a “buy” rating for the company in a research note on Monday, December 8th. Wall Street Zen cut shares of Sintx Technologies from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Sintx Technologies in a research report on Thursday, January 22nd. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $16.00.

Sintx Technologies Trading Down 0.7%

The company has a market capitalization of $10.20 million, a P/E ratio of -0.49 and a beta of 0.67. The business has a 50 day moving average price of $3.33 and a 200 day moving average price of $3.68.

Insider Buying and Selling at Sintx Technologies

In other Sintx Technologies news, CIO Gregg R. Honigblum acquired 65,000 shares of the business’s stock in a transaction dated Friday, December 5th. The shares were acquired at an average price of $3.93 per share, for a total transaction of $255,450.00. Following the acquisition, the executive directly owned 139,000 shares of the company’s stock, valued at approximately $546,270. This trade represents a 87.84% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In the last quarter, insiders bought 77,200 shares of company stock worth $302,352. Insiders own 4.08% of the company’s stock.

Institutional Trading of Sintx Technologies

Hedge funds have recently bought and sold shares of the stock. Virtus Wealth Solutions LLC bought a new stake in shares of Sintx Technologies during the third quarter worth $388,000. Veracity Capital LLC boosted its stake in Sintx Technologies by 10.3% in the 3rd quarter. Veracity Capital LLC now owns 79,928 shares of the company’s stock worth $327,000 after purchasing an additional 7,464 shares during the period. Finally, Geode Capital Management LLC increased its holdings in Sintx Technologies by 53.4% during the 4th quarter. Geode Capital Management LLC now owns 26,624 shares of the company’s stock worth $103,000 after purchasing an additional 9,265 shares in the last quarter. 18.38% of the stock is currently owned by institutional investors and hedge funds.

About Sintx Technologies

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.